 Receptors, Vasopressin
"Receptors, Vasopressin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors.
| Descriptor ID |
D017483
|
| MeSH Number(s) |
D12.776.543.750.695.910 D12.776.543.750.720.600.925 D12.776.543.750.750.555.925 D12.776.543.750.750.660.900
|
| Concept/Terms |
Receptors, Vasopressin- Receptors, Vasopressin
- Antidiuretic Hormone Receptors
- Hormone Receptors, Antidiuretic
- Receptors, Antidiuretic Hormone
- Vasopressin Receptor
- Receptor, Vasopressin
- Vasopressin Receptors
Vasopressin V1a Receptor- Vasopressin V1a Receptor
- Vasopressin Type 1A Receptor
- Antidiuretic Hormone Receptor 1a
- Vascular-Hepatic Type Arginine Vasopressin Receptor
- Vascular Hepatic Type Arginine Vasopressin Receptor
- V1a Vasopressin Receptor
Vasopressin V2 Receptor- Vasopressin V2 Receptor
- Receptors, V2
- Antidiuretic Hormone Receptor
- Hormone Receptor, Antidiuretic
- Receptor, Antidiuretic Hormone
- Renal-Type Arginine Vasopressin Receptor
- Renal Type Arginine Vasopressin Receptor
- V2 Receptor
- Receptor, V2
- V2 Receptors
Vasopressin Receptor 1- Vasopressin Receptor 1
- Receptors, V1
- V1 Receptors
- 8-Arg-Vasopressin Receptor
- 8 Arg Vasopressin Receptor
- Argipressin Receptors
- Receptors, Argipressin
- Receptor, Arginine(8)-Vasopressin
- Argipressin Receptor
- Receptor, Argipressin
- V1 Receptor
- Receptor, V1
- Arginine Vasopressin Receptor
- Receptor, Arginine Vasopressin
Vasopressin V1b Receptor- Vasopressin V1b Receptor
- Receptor, Vasopressin V1b
- V1b Receptor, Vasopressin
- Antidiuretic Hormone Receptor 1b
- Vasopressin V3 Receptor
- Receptor, Vasopressin V3
- V1b Vasopressin Receptor
- Vasopressin Receptor, V1b
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Vasopressin".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Vasopressin [D12.776.543.750.695.910]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Vasopressin [D12.776.543.750.720.600.925]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Vasopressin [D12.776.543.750.750.555.925]
- Receptors, Pituitary Hormone [D12.776.543.750.750.660]
- Receptors, Vasopressin [D12.776.543.750.750.660.900]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Vasopressin".
This graph shows the total number of publications written about "Receptors, Vasopressin" by people in this website by year, and whether "Receptors, Vasopressin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 1 | 1 | | 1993 | 0 | 1 | 1 | | 1995 | 1 | 0 | 1 | | 2003 | 0 | 1 | 1 | | 2008 | 2 | 0 | 2 | | 2010 | 1 | 0 | 1 | | 2011 | 0 | 1 | 1 | | 2012 | 2 | 1 | 3 | | 2013 | 1 | 1 | 2 | | 2014 | 2 | 0 | 2 | | 2016 | 0 | 1 | 1 | | 2017 | 0 | 1 | 1 | | 2018 | 1 | 1 | 2 | | 2019 | 3 | 0 | 3 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Vasopressin" by people in Profiles.
-
Dwivedi N, Tao S, Jamadar A, Sinha S, Howard C, Wallace DP, Fields TA, Leask A, Calvet JP, Rao R. Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease. J Am Soc Nephrol. 2020 08; 31(8):1697-1710.
-
García-Arroyo FE, Muñoz-Jiménez I, Gonzaga G, Tapia E, Osorio-Alonso H, Roncal-Jiménez CA, Iroz A, Vecchio M, Reyes-García JG, Johnson RJ, Sánchez-Lozada LG. A Role for Both V1a and V2 Receptors in Renal Heat Stress Injury Amplified by Rehydration with Fructose. Int J Mol Sci. 2019 Nov 16; 20(22).
-
Sinha S, Dwivedi N, Tao S, Jamadar A, Kakade VR, Neil MO, Weiss RH, Enders J, Calvet JP, Thomas SM, Rao R. Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. Oncogene. 2020 02; 39(6):1231-1245.
-
Lee W, Hiura LC, Yang E, Broekman KA, Ophir AG, Curley JP. Social status in mouse social hierarchies is associated with variation in oxytocin and vasopressin 1a receptor densities. Horm Behav. 2019 08; 114:104551.
-
Hiura LC, Ophir AG. Interactions of sex and early life social experiences at two developmental stages shape nonapeptide receptor profiles. Integr Zool. 2018 Nov; 13(6):745-760.
-
Sadino JM, Donaldson ZR. Prairie Voles as a Model for Understanding the Genetic and Epigenetic Regulation of Attachment Behaviors. ACS Chem Neurosci. 2018 08 15; 9(8):1939-1950.
-
García-Arroyo FE, Tapia E, Blas-Marron MG, Gonzaga G, Silverio O, Cristóbal M, Osorio H, Arellano-Buendía AS, Zazueta C, Aparicio-Trejo OE, Reyes-García JG, Pedraza-Chaverri J, Soto V, Roncal-Jiménez C, Johnson RJ, Sánchez-Lozada LG. Vasopressin Mediates the Renal Damage Induced by Limited Fructose Rehydration in Recurrently Dehydrated Rats. Int J Biol Sci. 2017; 13(8):961-975.
-
Roncal-Jimenez CA, Milagres T, Andres-Hernando A, Kuwabara M, Jensen T, Song Z, Bjornstad P, Garcia GE, Sato Y, Sanchez-Lozada LG, Lanaspa MA, Johnson RJ. Effects of exogenous desmopressin on a model of heat stress nephropathy in mice. Am J Physiol Renal Physiol. 2017 03 01; 312(3):F418-F426.
-
Hopp K, Wang X, Ye H, Irazabal MV, Harris PC, Torres VE. Effects of hydration in rats and mice with polycystic kidney disease. Am J Physiol Renal Physiol. 2015 Feb 01; 308(3):F261-6.
-
Tilley DG, Zhu W, Myers VD, Barr LA, Gao E, Li X, Song J, Carter RL, Makarewich CA, Yu D, Troupes CD, Grisanti LA, Coleman RC, Koch WJ, Houser SR, Cheung JY, Feldman AM. ß-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling. Circulation. 2014 Nov 11; 130(20):1800-11.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|